Health Technology · Pharmaceuticals: Major · NSE: FDC · data 2026-10-09
FDC Ltd.
Health check: Average (6.1/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹330.15
Market cap
₹5,281 cr
P/E
18.4
P/B
—
ROE
11.8%
ROCE
11.7%
Debt / equity
0.01
Dividend yield
1.54%
1-year return
-26.2%
52-week high
₹473.6
52-week low
₹312.95
Operating margin
13.2%
Growth
| Revenue (last 12 months) | ₹2,190 cr |
| Net profit (last 12 months) | ₹293 cr |
| Sales growth, 3 years (yearly) | 6.8% |
| Profit growth, 3 years (yearly) | 13.2% |
Chart patterns
- Double top — forming (key level ₹328.8)
Similar companies
Senores Pharmaceuticals Ltd. (SENORES) · Orchid Pharma Limited (ORCHPHARMA) · Novartis India Limited (NOVARTIND) · Gujarat Themis Biosyn Ltd (GUJTHEM) · RPG Life Sciences Limited (RPGLIFE)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open FDC in NSE Scanner →